ArticleClinical & translational immunology2022

Probabilistic classification of anti-SARS-CoV-2 antibody responses improves seroprevalence estimates.

Xaquin Castro Dopico et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.